Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection.

MLA

Khandelwal, Priyank, et al. “Severe Epistaxis after Tissue Plasminogen Activator Administration for Acute Ischemic Stroke in SARS-COV-2 Infection.” Brain Circulation, vol. 7, no. 2, Apr. 2021, pp. 135–38. EBSCOhost, https://doi.org/10.4103/bc.bc_17_21.

APA

Khandelwal, P., Martínez-Pías, E., Bach, I., Prakash, T., Hillen, M. E., Martínez-Galdámez, M., & Arenillas, J. F. (2021). Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection. Brain Circulation, 7(2), 135–138. https://doi.org/10.4103/bc.bc_17_21

Chicago

Khandelwal, Priyank, Enrique Martínez-Pías, Ivo Bach, Tannavi Prakash, Machteld E. Hillen, Mario Martínez-Galdámez, and Juan F. Arenillas. 2021. “Severe Epistaxis after Tissue Plasminogen Activator Administration for Acute Ischemic Stroke in SARS-COV-2 Infection.” Brain Circulation 7 (2): 135–38. doi:10.4103/bc.bc_17_21.